Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2017-04-05 | 2017-04-04 |
| Drug Identification Number | 02225107 | 02225107 |
| Brand name | CLAFORAN - PWS INJ 2.0G/VIAL | CLAFORAN - PWS INJ 2.0G/VIAL |
| Common or Proper name | CLAFORAN 2G X 10 VIALS | CLAFORAN 2G X 10 VIALS |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | CEFOTAXIME SODIUM | CEFOTAXIME SODIUM |
| Strength(s) | 2G | 2G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 VIALS | 10 VIALS |
| ATC code | J01DD | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2017-03-31 | 2017-03-31 |
| Actual discontinuation date | 2017-04-04 | 2017-04-04 |
| Remaining supply date | 2017-03-31 | 2017-03-31 |
| Discontinuation status | Discontinued | To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |